CareDx (CDNA) Common Equity (2013 - 2026)

CareDx has reported Common Equity for 14 years, with the latest figure at $425.6 million in Q2 2026.

• Quarterly Common Equity rose 30.01% year-over-year to $425.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $425.6 million (up 30.01% YoY) and the FY2025 annual result came in at $303.1 million, down 19.91% from the prior year.
• Common Equity grew to $425.6 million in Q2 2026 per CDNA's latest filing, from $313.5 million in the prior quarter.
• Over five years, Common Equity peaked at $457.5 million in Q1 2022 and troughed at $256.2 million in Q1 2024.
• A 5-year average of $360.1 million and a median of $378.9 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2025: Common Equity plunged 39.35% in 2023, then jumped 48.05% in 2025.
• Over 5 years, Common Equity stood at $430.9 million in 2022, then slumped by 39.35% to $261.3 million in 2023, then surged by 44.81% to $378.4 million in 2024, then decreased by 19.91% to $303.1 million in 2025, then surged by 40.41% to $425.6 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $425.6 million, $313.5 million, and $303.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.